Renin–angiotensin–aldosterone system (RAAS) inhibitors prevented MMP-10 activation in a murine DKD model, suggesting that angiotensin II (Ang-II) could also activate a signaling pathway involved in MMP-10 expression regulation [8]. Here, AGT is linked to diabetic kidney disease.